[{"id":"1ef49231-d3c5-4d4a-8854-a2f058fce18c","acronym":"QUILT-2.018","url":"https://clinicaltrials.gov/study/NCT00813605","created_at":"2021-01-18T03:05:28.580Z","updated_at":"2024-07-02T16:37:28.176Z","phase":"Phase 2","brief_title":"QUILT-2.018: Safety \u0026 Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma","source_id_and_acronym":"NCT00813605 - QUILT-2.018","lead_sponsor":"NantCell, Inc.","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS mutation","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e 5-fluorouracil • irinotecan • leucovorin calcium • ganitumab (AMG 479) • conatumumab (AMG 655)"],"overall_status":"Completed","enrollment":" Enrollment 155","initiation":"Initiation: 03/01/2009","start_date":" 03/01/2009","primary_txt":" Primary completion: 01/01/2011","primary_completion_date":" 01/01/2011","study_txt":" Completion: 06/01/2012","study_completion_date":" 06/01/2012","last_update_posted":"2016-10-27"}]